Others
others
Research Areas
- Actin(12)
- Inhibitory Antibodies(229)
- Adenylate cyclase(31)
- AhR(13)
- Aldose reductase(27)
- Arginase(15)
- AT Receptors(1)
- Autotaxin(4)
- ATP citrate lyase (11)
- BCRP(16)
- ROR/RAR/RXR(99)
- Caged Compounds(3)
- Calmodulin protein kinase II(1)
- CaM kinase II(9)
- Carbonic Anhydrase(31)
- Cell Penetrating Peptide(2)
- Ceramidases(4)
- CERK(1)
- Collagen proline hydroxylase(1)
- COMT(12)
- Cytokine(4)
- dCTP Pyrophosphatase(1)
- DHODH(1)
- Diacylglycerol Kinase(1)
- DNA Stain(17)
- eIF2a(2)
- Endopeptidase(3)
- Enzyme Substrates / Activators(69)
- ES-FLI1/RHA(2)
- Farnesyl Diphosphate Synthase(1)
- FBPase(5)
- FLAP(10)
- Fluorescent Probes(305)
- GLI(4)
- Glycoprotein(5)
- Glycosylase(5)
- Saccharides and Glycosides(19)
- Glyoxalase I(1)
- GSNOR(2)
- Guanylate Cyclase (32)
- Guanylyl Cyclase(7)
- Gutathione S-transferase(12)
- Heme oxygenase(10)
- Hexokinase(6)
- Hydroxylases(10)
- IL Receptor(1)
- Imidazoline Receptors(20)
- IMPDH(1)
- Inositol Phosphatases(4)
- Lp-PLA2(1)
- LpxC(1)
- Matrix Metalloprotease(1)
- MDR multidrug resistance(44)
- Menin-MLL(5)
- MGMT(1)
- Mineralocorticoid Receptor(25)
- Miscellaneous Compounds(9)
- MyD88(14)
- Myosin(32)
- NAE(2)
- NADPH Oxidase(18)
- Nampt(29)
- Natriuretic Peptide Receptors(6)
- Nitric Oxide(74)
- Nuclear Receptors(14)
- Oxygenases/Oxidases(5)
- PDHK(10)
- PGC-1α(6)
- Pregnane X Receptors(2)
- Reductases(6)
- Renin(13)
- Retinoid X Receptors(11)
- Squalene epoxidase(4)
- SGK(12)
- sFRP-1(3)
- SPHK(19)
- Synthases/Synthetases(12)
- Tachykinin(6)
- Thrombopoietin Receptor(9)
- Thymidine phosphorylase(4)
- Transcription Factors(118)
- Transketolase(3)
- β(1,3)-D-Glucan Synthase(2)
- β-Lactamase(3)
- XAO(4)
- Others(1570)
- BMI-1(1)
- SOD(12)
- Homodimerizers(2)
- Renal Diseases(9)
- FAS(24)
- calmodulin(6)
- Protein synthesis(4)
- Epac(1)
- MAGL(20)
- exocytosis(1)
- peroxiredoxins(1)
- Glucosidase(47)
- Estrogen Receptor/ERR(204)
- Progesterone Receptor(40)
- Cyclase(6)
- Environmental Toxicology(241)
- Glycerolipid Lipases(15)
- Lipases(26)
- Multidrug-Resistance Proteins(8)
- Negative Controls(9)
- Nucleic Acid Turnover/Signaling(56)
- Organ- & System-Specific Toxicity(157)
- Pesticides(102)
- Pharmaceutical Impurities(35)
- Sulfotransferases(4)
- Tec(3)
- Toxicology(161)
- Xenobiotic Sensing(23)
- UDP Glucuronosyltransferases(46)
- Amino Acid Derivatives(51)
- Drug Intermediate(276)
- Drug Isomer(70)
- Insecticide(20)
- MOFs(329)
- Phytohormone(8)
- SHMT(6)
- Phosphoramidites(28)
Products Related to Others(4280)
- GC69428Mal-Gly-PAB-Exatecan-D-glucuronic acidCAS: 2763252-25-9Purity: >99.00%
Mal-Gly-PAB-Exatecan-D-glucuronic acid can be used for the synthesis of antibody-drug conjugates (ADCs). Mal-Gly-PAB-Exatecan-D-glucuronic acid is also useful in research and diagnosis related to cancer.
- GC69449MenA-IN-2Purity: >99.00%
MenA-IN-2 (Compound 11) is a 1,4-dihydroxy-2-naphthoate ester isoprenyltransferase (MenA) inhibitor. The IC50 value of MenA-IN-2 for inhibiting MenA is 22 μM, and the GIC50 value of MenA-IN-2 for anti-tuberculosis Mycobacterium tuberculosis (Mtb) activity is 10 μM. MenA-IN-2 can suppress the continuous spread of Mtb.
- GC69461MilategrastCAS: 859217-52-0Purity: >98.00%
Milategrast can be used as a cell adhesion inhibitor or cell infiltration inhibitor. In vitro, Milategrast inhibits the adhesion of Jurkat cells to human fibronectin with an IC50 of
- GC69477MLS001006105CAS: 455310-36-8Purity: >98.00%
MLS001006105 is used for biological sequencing targeting protein targets: nuclear lamin isoform A-delta10.
- GC69497MRT-2359CAS: 2803881-11-8Purity: >99.00%
MRT-2359 is an orally effective GSPT1 degrader with anti-tumor activity. It also inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells. MRT-2359 exhibits preferential activity in MYC-driven cell lines, such as N- and L-MYC high NSCLC and SCLC patient-derived xenografts (PDX).
- GC69500MRTX849 analog 24CAS: 2490716-96-4Purity: >98.00%
MRTX849 analog 24 is a probe for the KRAS G12C inhibitor MRTX849, used to study the function of MRTX849.
- GC69513MuvalaplinCAS: 2565656-70-2Purity: >99.00%
Muvalaplin (LY3473329) is an orally active lipoprotein(a) [Lp(a)] agent, and research on Muvalaplin oral agents is currently underway.
- GC69514MuzolimineCAS: 55294-15-0Purity: >99.00%
Muzolimine (BAY-g 282) is a slow and long-acting diuretic. Muzolimine produces a diuretic effect within the Henle's loop of the kidney and has antihypertensive properties. Muzolimine can be used in research on cardiovascular diseases.
- GC69519myo-Inositol trispyrophosphate hexa-triethylamineCAS: 851086-77-6Purity: >98.00%
myo-Inositol trispyrophosphate (ITPP) hexa-triethylamine is a salt of inositol tripyrophosphate (ITPP), which is a membrane permeability modulator of hemoglobin.
- GC69529N-Acetyldopamine dimer-1CAS: 315188-82-0Purity: >98.00%
N-Acetyldopamine dimer-1 is a derivative of 2-(3',4'-dihydroxyphenyl)-1,4-benzodiazepine. It has optical activity and can be isolated from the exuviae of Cryptotympana sp., a species of cicada commonly known as "Zentai" in traditional Chinese medicine.
- GC69531N-Acetyldopamine dimer-3CAS: 315188-81-9Purity: >98.00%
N-Acetyldopamine dimer-3 (compound 11) is a natural product found in Aspongopus chinensis.
- GC69540NCGC00138783 TFAPurity: >99.00%
NCGC00138783 TFA is a selective inhibitor targeting the CD47/SIRPα axis, with an IC50 of 50 μM. It directly blocks the interaction between CD47 and SIRPα.
- GC69546NelutroctivCAS: 2299177-09-4Purity: >99.00%
Nelutroctiv is an effective cardiac myofilament calcium sensitizer.
- GC69553NFAT Inhibitor-2CAS: 422546-87-0Purity: >98.00%
NFAT Inhibitor-2 is an effective calcineurin NFAT signaling inhibitor. Calcineurin is a serine/threonine protein phosphatase regulated by Ca2+ and calmodulin. NFAT Inhibitor-2 has potential in researching inflammatory diseases, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, uncontrolled cell proliferation and/or differentiation disorders, angiogenesis-related diseases, allergies, allergic reactions and hair loss (information taken from patent WO2016207212A1 compound 17).
- GC69560Nicotinic acid mononucleotide triethylaminePurity: >99.00%
In the biosynthesis of NAD+, Nicotinic acid mononucleotide triethylamine is formed from nicotinic acid (NA) through the action of nicotinic acid phosphoribosyltransferase. Nicotinate mononucleotide triethylamine serves as a substrate for nicotinamide mononucleotide/nicotinic acid mononucleotide adenylyltransferase.
- GC69567NitrosobiotinCAS: 56859-26-8Purity: >99.00%
Nitrosobiotin can be used to label secondary antibodies.
- GC69605Octakis-(6-bromo-6-deoxy)-γ-cyclodextrinCAS: 53784-84-2Purity: >98.00%
Octakis-(6-bromo-6-deoxy)-β-cyclodextrin is a β-cyclodextrin that has been fully brominated on the primary side and is commonly used as an intermediate in cyclodextrin modification.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC69399 | LP-184 | 924835-67-6 | >98.00% | |
LP-184 (compound 6) is an acyl fluoride ethylene analog that can inhibit tumor growth. LP-184 has effective anti-cancer activity in ovarian, colon, prostate and pancreatic cell lines and comes from patent WO2007019308A2. | ||||
| GC69421 | M3913 | 2379783-62-5 | >99.00% | |
M3913 is an anti-tumor compound. M3913 has anti-proliferative activity against cancer cells. | ||||
| GC69428 | Mal-Gly-PAB-Exatecan-D-glucuronic acid | 2763252-25-9 | >99.00% | |
Mal-Gly-PAB-Exatecan-D-glucuronic acid can be used for the synthesis of antibody-drug conjugates (ADCs). Mal-Gly-PAB-Exatecan-D-glucuronic acid is also useful in research and diagnosis related to cancer. | ||||
| GC69443 | MDH1-IN-1 | 2143463-31-2 | >99.00% | |
MDH1-IN-1 (Compound 5i) is an effective inhibitor of MDH1 with an IC50 of 6.79 μM. MDH1-IN-1 has the potential to be used in cancer research. | ||||
| GC69447 | MEL24 | 642072-48-8 | >98.00% | |
MEL24 is a type of Mdm2 E3 ligase inhibitor that reduces cell survival in a p53-dependent manner and increases sensitivity to DNA damaging agents. It is used for in vitro anti-tumor research. | ||||
| GC69449 | MenA-IN-2 | - | >99.00% | |
MenA-IN-2 (Compound 11) is a 1,4-dihydroxy-2-naphthoate ester isoprenyltransferase (MenA) inhibitor. The IC50 value of MenA-IN-2 for inhibiting MenA is 22 μM, and the GIC50 value of MenA-IN-2 for anti-tuberculosis Mycobacterium tuberculosis (Mtb) activity is 10 μM. MenA-IN-2 can suppress the continuous spread of Mtb. | ||||
| GC69461 | Milategrast | 859217-52-0 | >98.00% | |
Milategrast can be used as a cell adhesion inhibitor or cell infiltration inhibitor. In vitro, Milategrast inhibits the adhesion of Jurkat cells to human fibronectin with an IC50 of | ||||
| GC69473 | ML162-yne | 2883115-46-4 | >99.00% | |
ML162-yne is an effective GPX4 inhibitor affinity probe. | ||||
| GC69477 | MLS001006105 | 455310-36-8 | >98.00% | |
MLS001006105 is used for biological sequencing targeting protein targets: nuclear lamin isoform A-delta10. | ||||
| GC69483 | MODAG-001 | 2648041-72-7 | >98.00% | |
MODAG-001 can bind to synaptic nuclear protein fibrils in the rat brain. MODAG-001 is a candidate α-syn imaging probe. | ||||
| GC69497 | MRT-2359 | 2803881-11-8 | >99.00% | |
MRT-2359 is an orally effective GSPT1 degrader with anti-tumor activity. It also inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells. MRT-2359 exhibits preferential activity in MYC-driven cell lines, such as N- and L-MYC high NSCLC and SCLC patient-derived xenografts (PDX). | ||||
| GC69500 | MRTX849 analog 24 | 2490716-96-4 | >98.00% | |
MRTX849 analog 24 is a probe for the KRAS G12C inhibitor MRTX849, used to study the function of MRTX849. | ||||
| GC69503 | MS47134 | - | >99.50% | |
MS47134 is an effective and selective MRGPRX4 agonist with an EC50 of 149 nM. MS47134 can be used for the study of pain, itch, and mast cell-mediated hypersensitivity reactions. | ||||
| GC69513 | Muvalaplin | 2565656-70-2 | >99.00% | |
Muvalaplin (LY3473329) is an orally active lipoprotein(a) [Lp(a)] agent, and research on Muvalaplin oral agents is currently underway. | ||||
| GC69514 | Muzolimine | 55294-15-0 | >99.00% | |
Muzolimine (BAY-g 282) is a slow and long-acting diuretic. Muzolimine produces a diuretic effect within the Henle's loop of the kidney and has antihypertensive properties. Muzolimine can be used in research on cardiovascular diseases. | ||||
| GC69519 | myo-Inositol trispyrophosphate hexa-triethylamine | 851086-77-6 | >98.00% | |
myo-Inositol trispyrophosphate (ITPP) hexa-triethylamine is a salt of inositol tripyrophosphate (ITPP), which is a membrane permeability modulator of hemoglobin. | ||||
| GC69529 | N-Acetyldopamine dimer-1 | 315188-82-0 | >98.00% | |
N-Acetyldopamine dimer-1 is a derivative of 2-(3',4'-dihydroxyphenyl)-1,4-benzodiazepine. It has optical activity and can be isolated from the exuviae of Cryptotympana sp., a species of cicada commonly known as "Zentai" in traditional Chinese medicine. | ||||
| GC69531 | N-Acetyldopamine dimer-3 | 315188-81-9 | >98.00% | |
N-Acetyldopamine dimer-3 (compound 11) is a natural product found in Aspongopus chinensis. | ||||
| GC69540 | NCGC00138783 TFA | - | >99.00% | |
NCGC00138783 TFA is a selective inhibitor targeting the CD47/SIRPα axis, with an IC50 of 50 μM. It directly blocks the interaction between CD47 and SIRPα. | ||||
| GC69546 | Nelutroctiv | 2299177-09-4 | >99.00% | |
Nelutroctiv is an effective cardiac myofilament calcium sensitizer. | ||||
| GC69553 | NFAT Inhibitor-2 | 422546-87-0 | >98.00% | |
NFAT Inhibitor-2 is an effective calcineurin NFAT signaling inhibitor. Calcineurin is a serine/threonine protein phosphatase regulated by Ca2+ and calmodulin. NFAT Inhibitor-2 has potential in researching inflammatory diseases, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, uncontrolled cell proliferation and/or differentiation disorders, angiogenesis-related diseases, allergies, allergic reactions and hair loss (information taken from patent WO2016207212A1 compound 17). | ||||
| GC69560 | Nicotinic acid mononucleotide triethylamine | - | >99.00% | |
In the biosynthesis of NAD+, Nicotinic acid mononucleotide triethylamine is formed from nicotinic acid (NA) through the action of nicotinic acid phosphoribosyltransferase. Nicotinate mononucleotide triethylamine serves as a substrate for nicotinamide mononucleotide/nicotinic acid mononucleotide adenylyltransferase. | ||||
| GC69567 | Nitrosobiotin | 56859-26-8 | >99.00% | |
Nitrosobiotin can be used to label secondary antibodies. | ||||
| GC69605 | Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin | 53784-84-2 | >98.00% | |
Octakis-(6-bromo-6-deoxy)-β-cyclodextrin is a β-cyclodextrin that has been fully brominated on the primary side and is commonly used as an intermediate in cyclodextrin modification. | ||||
